For this study, researchers in Turkey set out to determine the effectiveness of balneotherapy in fibromyalgia management. They found that balneotherapy decreased depression, improved tender point sensitivity and lessened pain intensity.
In this single blind, randomized controlled clinical study, 50 women with fibromyalgia under pharmacological treatment were randomly assigned to either the balneotherapy (25) or the control (25) group, according to an abstract published on www.pubmed.gov. The patients in the balneotherapy group received two thermomineral water baths daily for two weeks in Tuzla Spa Center. The patients in the control group continued to have their medical treatment and routine daily life.
An investigator who was blinded to the study arms assessed the patients. All patients were assessed four times; at the beginning of the study, at the end of the second week, the first month, and the third month after balneotherapy, according to the abstract. Outcome measures of the study were pain intensity, Fibromyalgia Impact Questionnaire, Beck Depression Inventory, patient’s global assessment, investigator’s global assessment, SF-36 scores, and tender point count.
Balneotherapy was found to be superior at the end of the cure period in terms of pain intensity, Fibromyalgia Impact Questionnaire, Beck Depression Inventory, patient’s global assessment, investigator’s global assessment scores, and tender point count as compared to the control group, according to the abstract. The superiority of balneotherapy lasted up to the end of the third month, except for the Beck Depression Inventory score and the investigator’s global assessment score.
“It was concluded that balneotherapy provides beneficial effects in patients with fibromyalgia,” the researchers noted.
“Balneotherapy in fibromyalgia: a single blind randomized controlled clinical study” was published in the journal Rheumatology International.